Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an injection for intravenous use. It treats Gram‑positive bacterial infections, including skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and complicated infections such as osteomyelitis and endocarditis.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive infections. - Skin and soft‑tissue infections: eradicates Staphylococcus aureus and related pathogens, promoting wound healing. - Community‑acquired and nosocomial pneumonia: provides rapid bacterial clearance and improves respiratory function. - Osteomyelitis: penetrates bone tissue to eliminate persistent Gram‑positive organisms. - Endocarditis: achieves bactericidal activity against resistant strains, supporting cardiac valve recovery.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: mild to moderate intensity. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Anemia: reduction in red blood cell count.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: tingling or numbness in extremities. - Lactic acidosis: metabolic disturbance requiring urgent care. - Serotonin syndrome: risk when combined with serotonergic agents. - Optic neuropathy: visual disturbances, potentially irreversible. - Myelosuppression: bone‑marrow suppression affecting multiple cell lines.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Monitor blood counts: watch for thrombocytopenia and anemia. - Assess renal function: adjust therapy in severe impairment. - Avoid concomitant serotonergic drugs: risk of serotonin syndrome. - Use with caution in patients with a history of MAO inhibitor use. - Adjust dose in hepatic dysfunction: consider reduced exposure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid interacts with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may precipitate severe hypertension. - Serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants, tramadol): risk of serotonin syndrome. - Rifampin: induces metabolism, reducing linezolid plasma levels. - Anticoagulants (warfarin): may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: additive effect on bleeding tendency. - Phenytoin: may lower linezolid concentrations. - Cyclosporine: potential for increased neurotoxicity. - Digoxin: monitor for altered serum levels. - Ethanol: may exacerbate central nervous system side effects.